Omilancor mitigates the senescence of nucleus pulposus cells induced by DDP through targeting MAP2K6

CONCLUSIONS: Omilancor shows promise as a treatment for IDD by targeting MAP2K6-mediated cellular senescence.PMID:38517363 | DOI:10.18632/aging.205588

Source: Aging - March 22, 2024 Category: Biomedical Science Authors: Fang Yafeng Shi Xinpeng Wei Rong Cui Guofeng Source Type: research